NRD
SRDX

Nebula Research & Development’s Surmodics SRDX Stock Holding History

Nebula Research & Development’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,078
Closed -$321K – 441
2023
Q1 		$321K Buy
+14,078
New +$363K 0.57% 43

Other funds holding SRDX

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nebula Research & Development's SRDX Position: Q2 2023 in Review

Nebula Research & Development sold out of Surmodics (SRDX) in Q2 2023, closing a stake of 14,078 shares — an estimated $321K sold.

Nebula Research & Development first reported a position in SRDX in Q1 2023 and held it in 1 quarter. The position peaked at $321K in Q1 2023. 105 funds tracked by Wall St. Rank hold SRDX as of Q2 2023.

  • Nebula Research & Development reported no remaining Surmodics position as of Q2 2023 after selling out during the quarter.
  • Nebula Research & Development sold 14,078 Surmodics shares in Q2 2023, an estimated $321K.
  • Nebula Research & Development first reported a position in Surmodics in Q1 2023 and held it in 1 quarter.
  • Nebula Research & Development's Surmodics position peaked at $321K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Surmodics as of Q2 2023.

Based on Nebula Research & Development's 13F filing for Q2 2023, filed 14 Aug 2023.